Missing DUR and SCC Documentation Can Lead to Recoupment!
Many pharmacy teams are overwhelmed with the increasing daily workload. This can result in data entry staff creating shortcuts, like entering override codes to get claims processed. PAAS National® wants to remind pharmacies that lack of documentation to support clinical drug utilization review (DUR) or submission clarification codes (SCC) can put claims at risk of audit recoupment.
In particular, Express Scripts® and Prime Therapeutics® audit for DUR and SCC documentation. High dollar claims submitted with override codes are frequently flagged for audit. The Express Scripts® Provider Manual addresses Prospective/Concurrent Drug Utilization Alerts and the mitigating DUR override codes. The guidance compels the dispensing pharmacist to document the rationale for the override on the prescription. Pharmacists must be made aware of DUR messages at point-of-sale and use professional judgement before proceeding with dispensing. These DUR rejects are in place to prevent potential harm to patients. Allowing these claims to automatically be overridden without pharmacist review goes against the PBM Provider Manual, risks patient safety and can lead to claim recoupment. DUR codes can be found as follows: Pharmacists must review each Service Code and, using professional judgement, submit the appropriate Professional Service Code and Results of Service Code. Simply documenting the override codes utilized does not provide the auditor with explanation of why it was appropriate to use the code; be sure to have a full clinical note explaining the situation. This documentation must be accessible for auditor’s review. Claims billed with SCC codes also require documentation. Remember, the PBM can see the initial claim rejection and resubmission with an override code. This second claim is an easy target for audit. Here is a short list of commonly used SCC codes as defined by NCPDP: PAAS Tips:
- 2024 Self-Audit Series #9: Eye Drop Days’ Supply - November 20, 2024
- Self-Audit Series #8: Compound Prescriptions - October 21, 2024
- Medicare and Vaccine Billing: What You Need to Know - October 5, 2024